| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.091 | 0.05 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.099 | 0.05 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |